• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

  • Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • Countering AMR
  • COVID-19 Research
  • Digital Therapies
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

OHE Announces New Trustees and Board Chair

As Professor Mike Drummond and Professor Bengt Jonnson step down from the OHE Board of Trustees after more than a decade of service, OHE announces the appointment of Professor Margaret Kyle and Professor Werner Brouwer as replacements with Professor Anita…

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Limitations of CBO’s Simulation Model of New Drug Development as a Tool for PolicymakersRead more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes
  • PhRMA

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
When Generic Measures Fail to Reflect What Matters to Patients: Three Case StudiesRead more
© NCI/Unsplash
  • Health Technology Assessment…
  • Measuring and Valuing Outcomes
  • Canada

Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies

Cancer_WellcomeCollection_landscape
Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic TherapiesRead more
© WellcomeCollection
Close
OHE
  • All Publications

    Filter by:
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • Countering AMR
    • COVID-19 Research
    • Digital Therapies
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 10th January 2022

OHE Announces New Trustees and Board Chair

As Professor Mike Drummond and Professor Bengt Jonnson step down from the OHE Board of Trustees after more than a decade of service, OHE announces the appointment of Professor Margaret Kyle and Professor Werner Brouwer as replacements with Professor Anita…

Tim 3
Tim Watson
Share:

As Professor Mike Drummond and Professor Bengt Jonnson step down from the OHE Board of Trustees after more than a decade of service, OHE announces the appointment of Professor Margaret Kyle and Professor Werner Brouwer as replacements with Professor Anita Charlesworth becoming chair

As Professor Mike Drummond and Professor Bengt Jonnson step down from the OHE Board of Trustees after more than a decade of service, OHE announces the appointment of Professor Margaret Kyle and Professor Werner Brouwer as replacements with Professor Anita Charlesworth becoming chair.

In December, we announced that Professor Mike Drummond and Professor Bengt Jonnson were stepping down from the OHE Board of Trustees after more than a decade of service.

OHE is pleased to welcome two leading academics to the Board of Trustees. OHE Chief Executive, Professor Graham Cookson says, “We’re delighted to welcome Professors Kyle and Brouwer, two distinguished academics in their field, to the Board. They are real thought leaders blending heavyweight research credentials with experience advising national and European governments on health and life sciences policy, which is core to OHE’s mission.”

Professor Margaret Kyle is Professor of Economics and holder of the Chair in Markets for Technology and Intellectual Property at MINES ParisTech.

She is widely recognised as a global expert on innovation, productivity, and competition. She has numerous papers examining R&D productivity in the pharmaceutical industry, specifically the role of geographic and academic spillovers; the firm-specific and policy determinants of the diffusion of new products; generic competition; and the use of markets for technology.

Her recent work examines the effect of trade and IP policies on the level, location, and direction of R&D investment and competition. She also works on issues of innovation and access to therapies in developing countries.

As you would expect from such an eminent scholar, her work has been published in leading journals across economics, strategy, and health policy, including the Review of Economics and Statistics, RAND Journal of Economics, Journal of Public Economics, Management Science, and Health Affairs to name only a few.

Professor Kyle holds a PhD in economics from MIT and is an associate editor of the International Journal of Industrial Organization. She previously held positions at Carnegie Mellon University, Duke University, London Business School, and the Toulouse School of Economics, and is a visiting professor at the Kellogg School of Management at Northwestern University. 

The impact of Professor Kyle’s work extends beyond the academy. Her work informs countries and companies. She is a member of DG Competition’s Economic Advisory Group on Competition Policy. She is one of eleven independent academic economists advising the French Prime Minister and Minister of Economic Affairs on the country’s productivity and competitiveness.

And most importantly of all – she currently serves on the Research Committee for the Office of Health Economics. From January, Professor Kyle will also become Chair of the Research Committee.

Professor Werner Brouwer is a Professor of Health Economics and the Dean of the Erasmus School of Health Policy & Management (ESHPM) of the Erasmus University Rotterdam.

His research focuses on the methodology of welfare economic evaluations in health care covering topics like optimal decision rules, normative foundations of economic evaluations in health, measurement and valuation of informal care and productivity costs, incorporating equity considerations in economic evaluations as well as the monetary value of health gains. His research also extends into broader topics such as the link between economic evaluation and health policy, behavioural economics, and public health economics.

He has published extensively on these topics including in leading field journals like Health Economics, Journal of Health Economics, Medical Decision Making, Social Science & Medicine and British Medical Journal.

Professor Brouwer holds an MSc in Economics (1996) and a PhD in Health Economics (1999) from Erasmus and is an Honorary University Professor at the Corvinus University in Budapest, Hungary. Werner is also affiliated with the institute for Medical Technology Assessment and the Erasmus School of Economics. Werner is an Associate Editor of Health Economics and a member of the Editorial Boards of the European Journal of Health Economics, PharmacoEconomics and Cost-Effectiveness and Resource Allocation.

He is also a member of the European Commission Expert Panel on Effective Ways of Investing in Health and the independent chairman of the Foundation for Top Clinical Mental Health Care (TOPGGz) and chairs the Erasmus Initiative Smarter Choices for Better Health of the Erasmus University Rotterdam.

We hope to be able to announce our third new Trustee shortly.

New Chair of Trustees

We are also pleased to announce that one of our existing Trustees, Professor Anita Charlesworth CBE, will be taking over as Chair of Trustees effective 1st January 2022.

Anita has been a Trustee of the Office of Health Economics since June 2019 and is currently Chair of the OHE Policy Committee, making significant contributions across both roles. Graham Cookson OHE’s Chief Executive said: “It’s been a great pleasure to work with Anita over the past two years and the combination – across all three sectors – of skills and experience she brings is exceptionally rare. We’re fortunate to be able to work even more closely with Anita as OHE celebrates its 60th anniversary.”

Anita is the Director of Research and the REAL Centre (Research and Economic Analysis for the Long term) at the Health Foundation, and Honorary Professor in the College of Social Sciences at the Health Services Management Centre (HSMC) at the University of Birmingham.

She is a health economist with an extensive background in government and public policy. Before joining the Health Foundation, she was Chief Economist at the Nuffield Trust from 2010–14, and previously had roles as Chief Analyst and Chief Scientific Advisor at DCMS (2007–10), Director of Public Spending at the Treasury (1998–2007) and worked as an Economic Advisor at the Department of Health and for SmithKline Beecham pharmaceuticals. 

Anita is also Trustee for Tommy’s, the baby charity, and alongside her deep professional experience she brings significance experience in the management and governance of charities.

Welcoming the new Trustees, OHE’s new Chair Anita Charlesworth said: ‘I am delighted to be taking over as chair of the OHE – Professor Mike Drummond will be a very hard act to follow.  The last two years have reminded us all of the critical importance of health services and innovation.  OHE has an outstanding team of researchers with an excellent track record of work in this area.  I am looking forward to working with Professors Kyle and Brouwer to support OHE as it continues to improve knowledge and understanding of health systems and innovation.  The applied translational work they champion has never been more important.’

Related News

Prize event
  • News
  • January 2023

Professor Aidan Hollis wins first £40,000 OHE Policy Innovation Prize

Read more
  • News
  • July 2022

OHE is Leading Research to Develop an EQ-5D ‘Bolt-on’ for Hearing

Read more
MicrosoftTeams-image-6_0
  • News
  • June 2022

OHE’s 60th Anniversary Party – Celebrating Our Achievements and Looking Forward

Read more
patientcare_shutterstock_1190997985_landscape
  • News
  • May 2022

Patient Participation Awareness Week 2022

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 OHE

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!